Publications by authors named "Peter Hiatt"

Claim this Profile
E
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
Kris De Boeck, Anne Munck, Seth Walker, Albert Faro, Peter Hiatt

J Cyst Fibros· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.
Margaret Rosenfeld, Philip M Farrell, Margaret Kloster, Jonathan O Swanson, Thuy Vu, Peter W Hiatt

Eur Respir J· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain.
Ruth Ann Luna, Laura A Millecker, C Renee Webb, Sally K Mason, Elaine M Whaley, Peter W Hiatt

J Clin Microbiol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung function from infancy to preschool in a cohort of children with cystic fibrosis.
Lyndia C Brumback, Stephanie D Davis, Gwendolyn S Kerby, Margaret Kloster, Robin Johnson, Peter W Hiatt

Eur Respir J· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting.
Gwendolyn S Kerby, Margaret Rosenfeld, Clement L Ren, Oscar H Mayer, Lyndia Brumback, Peter Hiatt

Pediatr Pulmonol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis.
Clement L Ren, Margaret Rosenfeld, Oscar H Mayer, Stephanie D Davis, Margaret Kloster, Peter W Hiatt

Pediatr Pulmonol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Miriam M Treggiari, George Retsch-Bogart, Nicole Mayer-Hamblett, Umer Khan, Michal Kulich, Peter Hiatt

Arch Pediatr Adolesc Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.
Stephanie D Davis, Margaret Rosenfeld, Gwendolyn S Kerby, Lyndia Brumback, Margaret H Kloster, Peter W Hiatt

Am J Respir Crit Care Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
Ronald L Gibson, Julia Emerson, Nicole Mayer-Hamblett, Jane L Burns, Sharon McNamara, Peter Hiatt

Pediatr Pulmonol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis.
Daniel F Garcia, Peter W Hiatt, Alan Jewell, Shauna L Schoonover, Stanley G Cron

Pediatr Pulmonol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values.
Anastassios C Koumbourlis, Xin C Chen, J Sunil Rao, Mark D Schluchter, Kirk Easley, Peter Hiatt

Pediatr Pulmonol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis.
Robert K Ernst, David A D'Argenio, Jeffrey K Ichikawa, M Gita Bangera, Sara Selgrade, Peter Hiatt

Environ Microbiol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis.
Pedro A Piedra, Stanley G Cron, Alan Jewell, Nicole Hamblett, Ruth McBride, Peter W Hiatt

Vaccine· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
Ronald L Gibson, Julia Emerson, Sharon McNamara, Jane L Burns, Margaret Rosenfeld, Peter Hiatt

Am J Respir Crit Care Med· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis